reports
- GlobalData Healthcare Department
Reata Pharmaceuticals Inc (RETA) - Financial Analysis Review
Summary Reata Pharmaceuticals Inc (RETA) - Financial Analysis Review Summary Reata Pharmaceuticals Inc (RPI) focuses on the development of novel therapeutics to treat rare and life-threatening diseases. It develops drugs for various therapeutic areas which includes cardiovascular; ophthalmology; immune-oncology and rare diseases. The company’s lead product candidate, bardoxolone methyl is used for the treatment of pulmonary arterial hypertension and pulmonary hypertension. RPI’s another p...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.